Rubin advises clients on antitrust law and competition considerations, including antitrust litigation, compliance with the Hart-Scott-Rodino Act, and mergers and acquisitions. He has experience in matters before the US Department of Justice (DOJ) and the Federal Trade Commission (FTC) and navigates clients across industries, including biotechnology, financial technology, healthcare, medical devices and technology, pharmaceuticals, software, spirits, and TV broadcasting.